Polynovo | PNV - 流动资产



金融业
股票价格
AUD
资产
AUD 123.37M
现金及等价物
AUD 29.21M
销售成本
AUD 9.02M
流动资产
AUD 69.23M
流动负债
AUD 22.81M
债务
AUD 15.38M
EBIT
AUD 2.06M
EBITDA
AUD 3.89M
员工
301
EPS每股收益
AUD 0.01
股本和储备
AUD 83.14M
销售毛利
AUD 61.26M
债务利息支出
AUD 506K
贷款资金
AUD 15.39M
市值
AUD 783.41M
净收入
AUD 3K
营业费用
AUD 68.22M
营业利润
AUD 2.06M
普通股股本
AUD 690.84M
PE价格收益
58.54
税前利润
AUD 1.96M
销售收入
AUD 70.33M
销售和管理费用
AUD 17.05M
股票
AUD 8.97M
贸易债权人
AUD 4.9M
应收帐款人
AUD 24.21M


流动资产 更改 日
Alcidion AUD 28.52M 4.83M 2025-12
Ansell USD 1.11B 5.2M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Cochlear AUD 1.37B 43.9M 2025-12
CSL USD 11.85B 1000K 2025-12
Healius AUD 1.04B 737.9M 2024-12
Integral Diagnostics AUD 74.82M 9.15M 2024-06
Mayne Pharma AUD 460.59M 14.71M 2024-06
Nanosonics AUD 234.13M 8.81M 2025-12
Ramsay Health Care AUD 3.56B 480.3M 2025-12
ResMed USD 3.82B 193.06M 2025-12
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Telix Pharmaceuticals AUD 330.28M 67.73M 2025-12